Patterns of Drug Resistance and Bacterial Pathogen Distribution in Patients with Urinary Tract Infections in the Jiaxing Region from 2020 to 2022

References

• Li J, Jiang F, Xie A, et al. Analysis of the distribution and drug resistance of pathogens in patients with urinary tract infection in the Eastern Chongming area of Shanghai from 2018 to 2020. Infect Drug Resist. 2022;15:6413–6422. doi:10.2147/IDR.S384515
   PubMed Web of Science ®Google Scholar
• Choi H, Shin K, Kim Y, et al. Characteristics of Escherichia coli urine isolates and risk factors for secondary bloodstream infections in patients with urinary tract infections. Microbiol Spectr. 2022;10(4):e0166022. doi:10.1128/spectrum.01660-22
   PubMed Web of Science ®Google Scholar
• Rozwadowski M, Gawel D. Molecular factors and mechanisms driving multidrug resistance in uropathogenic Escherichia coli—an update. Genes. 2022;13(8):1397. doi:10.3390/genes13081397
   PubMed Web of Science ®Google Scholar
• Mclellan L, Hunstad D. Urinary tract infection: pathogenesis and outlook. Trends Mol Med. 2016;22(11):946–957. doi:10.1016/j.molmed.2016.09.003
   PubMed Web of Science ®Google Scholar
• Rao C, Vennila T, Kosanam S, et al. Assessment of bacterial isolates from the urine specimens of urinary tract infected patient. Biomed Res Int. 2022;4088187. doi:10.1155/2022/4088187
   Google Scholar
• Islam M, Islam M, Khan R, et al. Prevalence, etiology and antibiotic resistance patterns of community-acquired urinary tract infections in Dhaka, Bangladesh. PLoS One. 2022;17:e0274423. doi:10.1371/journal.pone.0274423
   PubMed Web of Science ®Google Scholar
• Sokhn ES, Salami A, Roz AE, et al. Antimicrobial susceptibilities and laboratory profiles of Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates as agents of urinary tract infection in Lebanon: paving the way for better diagnostics. Med Sci. 2020;8(3):32. doi:10.3390/medsci8030032
   Google Scholar
• Lee D, Lee S-J, Choe H-S. Community-acquired urinary tract infection by Escherichia coli in the era of antibiotic resistance. Biomed Res Int. 2018;7656752. doi:10.1155/2018/7656752
   Google Scholar
• Miranda-Novales M, Flores-Moreno K, López-Vidal Y, et al. Limited therapeutic options in Mexico for the treatment of urinary tract infections. Antibiotics. 2022;11:1656. doi:10.3390/antibiotics11111656
   Google Scholar
• Ezzeddine Z, Ghssein G. Towards new antibiotics classes targeting bacterial metallophores. Microb Pathog. 2023;182:106221. doi:10.1016/j.micpath.2023.106221
   PubMed Web of Science ®Google Scholar
• Jalil M, Naji Al Atbee M. The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections. J Clin Lab Anal. 2022;36(9):e24619. doi:10.1002/jcla.24619
   PubMed Web of Science ®Google Scholar
• Adamus-Bialek W, AnnaWawszczak M, StanislawGad B, KlaudiaBator P, MartaParniewski P. The genetic background of antibiotic resistance among clinical uropathogenic Escherichia coli strains. Mol Biol Rep. 2018;45(5):1055–1065. doi:10.1007/s11033-018-4254-0
   PubMed Web of Science ®Google Scholar
• Sugianli AK, Ginting F, Parwati I, et al. Antimicrobial resistance among uropathogens in the Asia-Pacific region: a systematic review. JAC Antimicrob Resist. 2021;3(1):dlab003. doi:10.1093/jacamr/dlab003
   PubMedGoogle Scholar
• Mortazavi-Tabatabaei S, Ghaderkhani J, Nazari A, et al. Pattern of antibacterial resistance in urinary tract infections: a systematic review and meta-analysis. Int J Prev Med. 2019;10(1):169. doi:10.4103/ijpvm.IJPVM_419_17
   PubMedGoogle Scholar
• Silva A, Costa E, Freitas A, et al. Revisiting the frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections. Antibiotics. 2022;11(6):768. doi:10.3390/antibiotics11060768
   Google Scholar
• Lu X, Wang Y, Guo W, et al. Antibacterial activity of an FtsZ inhibitor celastrol and its synergistic effect with vancomycin against enterococci in vitro and in vivo. Microbiol Spectr. 2023;11:e0369922. doi:10.1128/spectrum.03699-22
   PubMed Web of Science ®Google Scholar
• Joya M, Aalemi AK, Baryali T. Prevalence and antibiotic susceptibility of the common bacterial uropathogen among UTI patients in French medical institute for children. Infect Drug Resist. 2022;15:4959–4960. doi:10.2147/IDR.S387390
   PubMed Web of Science ®Google Scholar
• Vallo S, Wirth P, Kukic A, et al. Decreasing susceptibility of bacteria to ampicillin/ sulbactam and third generation cephalosporins in urinary tract infections. Curr Urol. 2022;16(2):94–98. doi:10.1097/CU9.0000000000000079
   PubMedGoogle Scholar
• Salm J, Salm F, Arendarski P, et al. High antimicrobial resistance in urinary tract infections in male outpatients in routine laboratory data, Germany, 2015 to 2020. Eurosurveillance. 2022;27(30):2101012. doi:10.2807/1560-7917.ES.2022.27.30.2101012
   Web of Science ®Google Scholar
• Wojno K, Baunoch D, Luke N, et al. Multiplex PCR based Urinary Tract Infection (UTI) analysis compared to traditional urine culture in identifying significant pathogens in symptomatic patients. Urology. 2019;136:119–126. doi:10.1016/j.urology.2019.10.018
   PubMedGoogle Scholar
• Costa T, Linhares I, Ferreira R, et al. Frequency and antibiotic resistance of bacteria implicated in community urinary tract infections in North Aveiro between 2011 and 2014. Microb Drug Resist. 2018;24:493–504. doi:10.1089/mdr.2016.0318
   PubMed Web of Science ®Google Scholar
• Rowe TA, Juthani-Mehta M. Diagnosis and management of urinary tract infection in older adults. Infect Dis Clin North Am. 2014;28(1):75–89. doi:10.1016/j.idc.2013.10.004
   PubMed Web of Science ®Google Scholar
• Mohd R, Akhtar M, Najmi A, Singh K. Escherichia coli and Klebsiella pneumoniae sensitivity/resistance pattern towards antimicrobial agents in primary and simple urinary tract infection patients visiting university hospital of Jamia Hamdard New Delhi. Drug Res. 2018;68(7):415–420. doi:10.1055/a-0576-0079
   Web of Science ®Google Scholar
• Ríos E, Diaz M, Culebras E, et al. Resistance to fosfomycin is increasing and is significantly associated with extended-spectrum β-lactamase-production in urinary isolates of Escherichia coli. Med Microbiol Immunol. 2022;211(5–6):269–272. doi:10.1007/s00430-022-00749-2
   PubMed Web of Science ®Google Scholar
• Barbara K, Wicha J, Grużewska A, et al. Virulence factors, biofilm-forming ability, and antimicrobial resistance of urinary Escherichia coli strains isolated from hospitalized patients. Turk J Med Sci. 2016;46:1908–1914. doi:10.3906/sag-1508-105
   PubMed Web of Science ®Google Scholar
• Prakash D, Saxena RS. Distribution and antimicrobial susceptibility pattern of bacterial pathogens causing urinary tract infection in urban community of Meerut City, India. ISRN Microbiol. 2013;2013:749629. doi:10.1155/2013/749629
   PubMedGoogle Scholar
• Shrief R, El-Ashry A, Mahmoud R, et al. Effect of colistin, fosfomycin and meropenem/vaborbactam on carbapenem-resistant Enterobacterales in Egypt: a cross-sectional study. Infect Drug Resist. 2022;15:6203–6214. doi:10.2147/IDR.S385411
   PubMed Web of Science ®Google Scholar
• Carvalhaes CG, Shortridge D, Sader HS, et al. Activity of meropenem-vaborbactam against bacterial isolates causing pneumonia in hospitalized patients from U.S. Hospitals during 2014 to 2018. Antimicrob Agents Chemother. 2020;64(3). doi:10.1128/AAC.02177-19
   Web of Science ®Google Scholar
• Ballash G, Mollenkopf D, Diaz-Campos D, et al. Pathogenomics and clinical recurrence influence biofilm capacity of Escherichia coli isolated from canine urinary tract infections. PLoS One. 2022;17:e0270461. doi:10.1371/journal.pone.0270461
   PubMed Web of Science ®Google Scholar
• Ch’ng JH, Chong K, Ling NL, et al. Biofilm-associated infection by enterococci. Nat Rev Microbiol. 2018;17(2):82–94. doi:10.1038/s41579-018-0107-z
   Web of Science ®Google Scholar
• Rao C, Dhawan B, Vishnubhatla S, et al. Emergence of high-risk multidrug-resistant Enterococcus faecalis CC2 (ST181) and CC87 (ST28) causing healthcare-associated infections in India. Infect Genet Evol. 2020;85(6890):104519. doi:10.1016/j.meegid.2020.104519
   PubMedGoogle Scholar
• Gajdács M, Brók M, Lázár A, et al. Increasing relevance of Gram-positive cocci in urinary tract infections: a 10-year analysis of their prevalence and resistance trends. Sci Rep. 2020;10(1):17658. doi:10.1038/s41598-020-74834-y
   PubMed Web of Science ®Google Scholar
• Asfaw T. Biofilm formation by Enterococcus Faecalis and Enterococcus Faecium: review. ARC J. 2019;2019:2349–2365. doi:10.20431/2349-0365.0704002
   Google Scholar
• Guclu E, Halis F, Kose E, et al. Risk factors of multidrug-resistant bacteria in community-acquired urinary tract infections. Afr J Online. 2021;1:214–219. doi:10.4314/ahs.v21i1.28
   Google Scholar